Xu F Y, Zhai Z G
Peking University China-Japan Friendship School of Clinical Medicine, Beijing 100029, China.
Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Jun 12;45(6):588-592. doi: 10.3760/cma.j.cn112147-20220225-00154.
In the past year, significant progress has been made in the field of venous thromboembolism (VTE) including risk assessment and anticoagulation prevention, diagnostic strategies and model exploration, new drug development and disease management. Particularly, major breakthroughs have been made in the prevention of VTE with FXI inhibitors and the prevention of novel coronavirus pneumonia with coagulation alterations and anticoagulation interventions. Here, we reviewed the progress and achievements in the field of VTE in the past year, aiming to provide evidence and ideas for the diagnosis, treatment and future studies of VTE.
在过去一年中,静脉血栓栓塞症(VTE)领域取得了重大进展,包括风险评估与抗凝预防、诊断策略与模型探索、新药研发及疾病管理。特别是,在使用FXI抑制剂预防VTE以及利用凝血改变和抗凝干预措施预防新型冠状病毒肺炎方面取得了重大突破。在此,我们回顾了过去一年VTE领域的进展与成果,旨在为VTE的诊断、治疗及未来研究提供依据和思路。